UK markets closed
  • FTSE 100

    6,915.75
    -26.47 (-0.38%)
     
  • FTSE 250

    22,251.26
    +3.72 (+0.02%)
     
  • AIM

    1,236.50
    -2.54 (-0.21%)
     
  • GBP/EUR

    1.1510
    -0.0012 (-0.11%)
     
  • GBP/USD

    1.3706
    -0.0029 (-0.21%)
     
  • BTC-GBP

    44,272.09
    +1,321.10 (+3.08%)
     
  • CMC Crypto 200

    1,235.89
    +8.34 (+0.68%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.03 (+0.89%)
     
  • CRUDE OIL

    59.34
    -0.26 (-0.44%)
     
  • GOLD FUTURES

    1,744.10
    -14.10 (-0.80%)
     
  • NIKKEI 225

    29,768.06
    +59.08 (+0.20%)
     
  • HANG SENG

    28,698.80
    -309.27 (-1.07%)
     
  • DAX

    15,234.16
    +31.48 (+0.21%)
     
  • CAC 40

    6,169.41
    +3.69 (+0.06%)
     

Menhaden Plc - Director Declaration

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

23 March 2021

MENHADEN PLC
(the “Company”)

Director Declaration

In accordance with Listing Rule 9.6.14, Menhaden PLC announces that Sir Ian Cheshire, Chairman of the Company, joined the Board of Spire Healthcare Group plc as director and chairman-designate with effect from 4 March 2021. He will accede to the role of chairman following Spire Healthcare Group plc’s annual general meeting in May 2021.

For further information please contact:

Frostrow Capital LLP
Company Secretary
Tel: 020 3709 8734